Publizoom

Award notice Supplies

Cbam 494/2025 janssen cilag/28

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
Servicio Andaluz de Salud
Sevilla
Place of performance
MÁLAGA
Estimated value
€353,000 excl. VAT
Amount awarded
€353,000 excl. VAT
Planned end of contract
26 September 2027
likely re-tender around March 2027
Bids received
1
Procedure
oth-single
Publication
23 October 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC DE SEVILLA,CÓRDOBA Y MÁLAGA,MEDIANTE PROC.NEG.SIN PUBLIC.CON EMPRESA JANSSEN-CILAG,SA,TRAMITE URGENTE

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€350,000
Median
€846,164
A quarter above
€2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Adjudicación del Contrato Específico del Medicamento BROLUCIZUMAB 120 MG / ML, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral
Consorci Sanitari Integral · 23 October 2026
NOVARTIS FARMACÉUTICA, S.A. €594,017
Suministro de IODIXANOL (VISIPAQUE) E IOHEXOL (OMNIPAQUE) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos
HOSPITAL CLINICO SAN CARLOS · 23 October 2026
GE HEALTHCARE BIO-SCIENCES, SAU €505,350
Suministro de Tafasitamab (DOE)
OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026
INCYTE BIOSCIENCES IBERIA, S.L. €2,170,000
Adjudicación del Contrato Específico del Medicamento FUMARATO DE DIROXIMEL, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral
Consorci Sanitari Integral · 23 October 2026
BIOGEN SPAIN S.L. €277,262
Suministro de medicamentos exclusivos del laboratorio VIIV HEALTHCARE S.L. para la Gerencia de Atención Sanitaria de Melilla
Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria · 23 October 2026
LABORATORIOS VIIV HEALTHCARE S.L. €126,595

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 734345-2026.